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Abstract
Chlamydia trachomatis (Ct) is the most common sexually transmitted bacterial pathogen,
and the leading cause of infectious blindness worldwide. We have recently shown that
immunization with the highly conserved antigenic passenger domain of recombinant Ct
polymorphic membrane protein D (rPmpD) is protective in the mouse model of Ct genital
tract infection, and previously, that ocular anti-rPmpD antibodies are elicited following vacci-
nation. However, the mechanisms governing the assembly and structure-function relation-
ship of PmpD are unknown. Here, we provide a biophysical analysis of this immunogenic 65
kDa passenger domain fragment of PmpD. Using differential cysteine labeling coupled with
LC-MS/MS analysis, we show that widespread intra- and intermolecular disulphide interac-
tions play important roles in the preservation of native monomeric secondary structure and
the formation of higher-order oligomers. While it has been proposed that FxxN and GGA(I,
L,V) repeat motifs in the Pmp21 ortholog in Chlamydia pneumoniae mediate self-interaction,
no such role has previously been identified for cysteine residues in chlamydial Pmps. Fur-
ther characterisation reveals that oligomeric proteoforms and rPmpD monomers adopt ȕ–
sheet folds, consistent with previously described Gram-negative bacterial type V secretion
systems (T5SSs). We also highlight adhesin-like properties of rPmpD, showing that both
soluble rPmpD and anti-rPmpD serum from immunized mice abrogate binding of rPmpD-
coated beads to mammalian cells in a dose-dependent fashion. Hence, our study provides
further evidence that chlamydial Pmps may function as adhesins, while elucidating yet
another important mechanism of self-association of bacterial T5SS virulence factors that
may be unique to the Chlamydiaceae.
Introduction
Chlamydia trachomatis (Ct) is a Gram-negative obligate intracellular pathogen of humans, and
the etiological agent of blinding trachoma and sexually transmitted diseases [1]. Ocular Ct
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serovars (A-C) primarily infect human conjunctival epithelial cells, with repeated infections
leading to corneal opacity and subsequent blindness. Collectively, serovars (D-K) and lympho-
granuloma venereum (LGV) strains (L1-L3) are the most common sexually transmitted bacte-
rial pathogens worldwide, responsible for ~131 million new cases each year [2]. Urogenital
infections are asymptomatic in 70–90% of women, with untreated ascending infections the
main cause of substantial morbidity and post-infection sequelae such as pelvic inflammatory
disease, ectopic pregnancies and infertility [3]. Thus, efficacious vaccine design remains a high
public health priority.
In light of recently identified chimeric variation and recombination within the ompA
genetic locus encoding the major outer membrane protein (MOMP) which comprised the
mainstay of chlamydial vaccine development for over two decades [4], chlamydial polymor-
phicmembrane proteins (Pmps) have more recently elicited widespread interest as candidate
vaccine immunogens. This is largely due to their surface-exposed nature and accessibility to
neutralising antibodies, a putative role in mediating adhesin-like function, as well as the abun-
dance of T-cell epitopes on these highly immunogenic proteins that are able to prime robust
cell-mediated immunity [5–8]. Pmps are part of a large and diverse family of type V autotran-
sporter (T5SSs) proteins within the Chlamydiaceae. T5SSs are thought to comprise the largest
family of secreted proteins in Gram-negative bacteria [9], and Ct possesses nine Pmps (Pmp
A-I) within its genomic repertoire, representing roughly 13% of the total genomic coding
capacity [10]. The maintenance of such a large family of Pmps in a bacterial phylum that has
undergone evolution by genomic reduction, suggests either crucial or redundant roles for
these proteins in the life cycle of Ct.
Of these Pmps, PmpD is the most highly conserved, with 99.15% sequence identity between
the 18 reference serovars [11]. Swanson et al. report membrane-associated and soluble forms
of PmpD, with flower-like oligomeric structures (~23nm) observed on infectious elementary
bodies (EBs), that are thought to comprise full length (~155 kDa) and processed (~73 kDa and
~82 kDa) forms of PmpD, while Kiselev et al. reported processing of the 157 kDa passenger
domain to 65 kDa and 80 kDa fragments in intracellular metabolically active reticulate body
(RB) forms [12, 13]. Furthermore, post-translational processing of PmpD orthologs has been
reported in Chlamydia pneumoniae and Chlamydophila abortus [14, 15]. These studies demon-
strate that PmpD and its orthologs are surface-exposed and undergo post-translational pro-
cessing in a range of pathogenic chlamydial species.
Concomitant with nascent advances in the genetic manipulation of Ct, investigation of
PmpD function in vivowas addressed following truncation of the protein by chemical muta-
genesis using a targeted reverse genetics approach [16]. The pmpDmutant showed aberrant
inclusion morphology and reduced association of RBs with the inclusion membrane, but no
obvious growth defects. In addition, the mutant was significantly attenuated for virulence in
human endocervical and conjunctival cells when compared to the wild-type strain, suggesting
that PmpD plays a role in early interactions with host cells, as well as during biphasic develop-
ment within the inclusion membrane.
Leading on from these observations, we have recently shown that immunization with the
N-terminal 65 kDa passenger domain of rPmpD elicits protection against Ct genital tract
infection, which correlates with high levels of rPmpD-specific serum and cervico-vaginal IgG
titres even in the absence of a significantly elevated rPmpD-specific Th1-type cellular response
[8, 17]. Previously, we found that intramuscular immunization with rPmpD elicited ocular
antibodies, suggesting the potential utility of this pan-conserved antigen in clinical vaccine
development against both sexually transmitted infections and trachoma [8, 17].
An accumulating body of evidence in Chlamydia pneumoniae is now beginning to inform
the molecular interactions between Pmp21 (the ortholog of PmpD) and mammalian cells, and
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although no host cell ligand has been defined for any Ct Pmp, it has been shown that these
outer membrane proteins function as adhesins. It was first observed that FxxN and GGA(I,L,
V) repeat motifs influence host cell adhesion and self-interaction, and subsequently, that
mutating one of these repeat motifs in a truncated 23 kDa C-terminal recombinant Pmp21
fragment results in reduced ability to form oligomers [5, 18, 19]. PmpD contains 17 GGA(I,L,
V) and 19 FxxN tetrapeptide sequences that may indeed play similar roles in Ct, as these repeat
motifs are a characteristic feature of chlamydial autotransporter passenger domains, and
markedly over-represented in Pmps relative to the rest of the proteome [20]. This suggests that
chlamydial membrane protein assembly and host cell interactions may occur through unique
interfacial contacts particular to this ancient bacterial phylum. Indeed, in addition to repeat
motifs, the chlamydial outer membrane is also unique when compared to all other known
Gram-negative phyla due to the presence of an extensively oxidized disulphide-linked outer
membrane complex, which undergoes morphological changes during the life cycle of Ct. Ct
EBs consist primarily of MOMP and the two major cysteine-rich proteins OmcA and OmcB
[21]. However, following internalisation, the EB membrane undergoes disulphide reduction
and expansion within the intracellular chlamydial inclusion as the bacterium differentiates
into larger metabolically active RBs [21].
In this study, we investigated the mechanism of assembly and adhesion properties of the
recombinant N-terminal 65 kDa passenger domain fragment of PmpD (rPmpD) in vitro. We
provide a biophysical characterization of rPmpD, identifying for the first time, a unique role
for disulphide bonds in oligomerization and self-interaction of this T5SS protein, as well as in
the preservation of monomeric secondary structure, showing that all 18 cysteine residues are
disulphide-bonded in the dominant proteoforms. Circular dichroism analysis shows that
rPmpD consists primarily of Č–sheet secondary structure, which is consistent with biophysical
analyses presented for the truncated 23 kDa Pmp21 domain in Chlamydia pneumoniae, as well
as experimentally solved crystal structures of other Gram-negative bacterial T5SSs [18, 22].
Finally, we show that rPmpD possesses adhesin-like characteristics, and that both soluble
rPmpD and anti-rPmpD serum from immunized mice abrogate adhesion of rPmpD-coated
beads to the mammalian Hak cell line, highlighting a putative role for neutralizing anti-
rPmpD antibodies in in vitro studies, which is consistent with our previous observations in
vivo [8].
Materials and methods
Purification and preparation of rPmpD
Bacteria were induced with IPTG at an optical density of between 0.6–1.0. Following overnight
expression at 37˚C, bacteria were lysed by sonication in the following lysate buffer (20mM
Tris-HCl, pH 8.0 50mMNaCl, 5mM EDTA, 0.5% Triton-X100 and 0.1mM phenylmethylsul-
fonyl fluoride (PMSF)). Cells from 4 litres of culture were lysed in 250 mL of lysate buffer and
sonicated for a total of 10–15 minutes on ice in 10s bursts with 10s intervals. Following sonica-
tion, 10mMMgSO4 was added to chelate EDTA, and lysozyme (0.1 mg/mL) subsequently
added to the lysate and incubated at RT for 20min to facilitate cell lysis. Cell lysate was centri-
fuged (6000 rpm for 15 minutes) to collect inclusion bodies, and the pellet resuspended
completely once more by sonication in the lysate buffer. The final wash step was conducted
using lysate buffer without Triton-X100: 20mM Tris-HCl, pH 8.0 50mMNaCl, 5mM EDTA.
The washed inclusion body pellets were dispersed completely by sonication and then dis-
solved overnight at 4˚C by stirring vigorously, in 20mM Tris buffer (pH 8.0) containing 6M
GdHCl. 100 mL for 2L of culture was used at this dissolution stage. The following day, the
solution was centrifuged (6000 rpm for 20 minutes) to remove any insoluble particulates, and
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refolding of the rPmpD was conducted using step-wise dialysis by altering the concentration
of GdHCl from 6M to 4M to 2M to 1M over the course of 3 days at 4˚C. For refolding under
reducing conditions, 5mM reduced glutathione and 0.5mM oxidized glutathione were added
to the refolding buffer.
Recombinant PmpD was purified using a nickel-affinity chromatography column (GE
Healthcare) pre-equilibrated with binding buffer (20mM TrisHCl pH 8.0, 50mMNaCl, 10mM
imidazole), and protein was eluted with a linear imidazole gradient (10–500mM). Eluted frac-
tions were analysed by SDS–PAGE and those containing overexpressed protein (approxi-
mately 90% pure) were pooled, concentrated and then applied onto an S200 16/60 Superdex
gel-filtration column (GE Healthcare) pre-equilibrated with 20mM TrisHCl pH 8.0, 50mM
NaCl. Eluted fractions containing rPmpD were flash frozen in liquid nitrogen and stored at
−80˚C until further use.
Prior to use in in vitro assays and in vivo experiments, LPS phase separation was performed
as previously described [23]. Briefly, Triton X-114 detergent was added to rPmpD oligomeric
or monomeric fractions to a final concentration of 1% (v/v) and incubated at 4˚C for 30 mins
with constant rotation. The mixture was then transferred to a water bath at 37˚C for 10mins
followed by ultracentrifugation (20,000 g, 10 mins) to separate LPS-containing micelles from
the aqueous fraction. The aqueous supernatant was collected and endotoxin concentration
measured using the Limulus Amebocyte Lysate assay. The LAL assay was utilised to determine
the amount of endotoxin in the rPmpD preparation, which was found to be below 0.1 EU/mg.
Dynamic light scattering
The polydispersity of rPmpD oligomeric and monomeric fractions was analysed using
dynamic light scattering (DLS). Measurements were carried out at 20˚C with the protein at 1
mg/mL in size exclusion buffer using the DynaPro Dynamic Light Scattering system (Protein
Solutions).
Circular dichroism spectroscopy
Circular-dichroism (CD) spectra were recorded at 20˚C with a Jasco J-180 CD spectrophotom-
eter using a 0.1 cm path-length quartz cell. Experiments were carried out in 20mM Tris/HCl
buffer pH 8.0. The protein concentrations in the samples were 0.2 mg/mL. Random error and
noise were reduced for each spectrum by averaging three scans in the wavelength range
260nm–195 nm. The signal acquired for the buffer used for dilution of the proteins was sub-
tracted from the spectra acquired for the proteins.
SDS- and Native PAGE analyses
SDS-PAGE rPmpD samples were either denatured for 5 mins at 95˚C in sample loading buffer
(0.5M Tris-HCl–pH 6.8, 10% (w/v) glycerol, 2% (w/v) SDS, 0.005% Bromophenol Blue) prior
to gel loading, or exposed to loading buffer containing either Č–mercaptoethanol and/or SDS
without heating (as explicitly stated). Unstained broad range (2–212 kDa) protein marker
(NEB) was added to determine protein molecular weight, and samples were separated at 200V
for 35 mins in running buffer composed of 25 mM Tris, 250 mM glycine, 0.1% (w/v) SDS, pH
8.4, following loading on to 12% acrylamide SDS gels. All running and loading buffers for
Native PAGE were composed of the same constituents as in SDS PAGE, but without the addi-
tion of SDS detergent. Native samples were separated at 100V for 1hr on gels composed of 5%
acrylamide (without SDS). rPmpD concentration was measured using the Pierce Coomassie
(Bradford) Protein assay kit (ThermoFisher), with absorbance measured at 595nm on a UV
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Eppendorf Biophotometer after blanking with elution buffer. Unknown protein concentra-
tions were determined from the BSA protein standard curve provided.
Tryptic digests
Limited proteolysis was carried out on the 65 kDa rPmpD passenger domain in 10 μl reaction
mixtures with a final protein concentration of 0.2 mg mL−1 in 50 mM Tris–HCl (pH 7.5) and
50–150 mMNaCl. Trypsin (Hampton Research) was added, and the mixture incubated
between 0.5–30 mins. Following quenching of the reaction by addition of 1–10mM PMSF, the
products were analysed by SDS–PAGE.
Differential cysteine labelling
A 50μL aliquot of rPmpD in aqueous 20mM Tris pH 8.0 and 50mMNaCl, was diluted to
100 μL with aqueous 80 μM iodoacetamide and incubated for 30mins at room temperature.
The sample was buffer exchanged into aqueous 50mM ammonium bicarbonate using an Ami-
con 30 kDa spin filter (5 mins, 14,000 g). Concentrated protein was taken up to a final volume
of 120μL with aqueous 50 mM ammonium bicarbonate and split into three 40 μL aliquots for
parallel digestion with trypsin (Promega), chymotrypsin (Roche) and Asp-N (Sigma) sequenc-
ing grade proteases. A 0.2 μg aliquot of protease in 10 μL of 50mM ammonium bicarbonate
was added to each and incubated at 37˚C for 16h. Each digest was split into two aliquots, one
reduced with the addition of 2 μL 50 mM tris (2-carboxyethyl) phosphine (TCEP) and the
other treated with 2 μL 50 mM ammonium bicarbonate as a control. Both the aliquot contain-
ing the reductant and the control were heated at 60˚C for 1h before alkylating with 1.25 μL of
0.2 Mmethyl methanethiosulfonate (MMTS) and incubation at room temperature for 30
mins. Digests were acidified with aqueous 0.1% trifluoroacetic acid and 10 μL aliquots taken
from each of the three protease-derived peptide mixtures and combined to give one reduced
and one non-reduced sample, each of which had been subjected to the same alkylation regime.
Samples were loaded onto an UltiMate 3000 RSLCnano HPLC system (Thermo) equipped
with a PepMap 100 Å C18, 5μm trap column (300 μm x 5 mm Thermo) and a PepMap, 2 μm,
100 Å, C18 EasyNano nanocapillary column (75μm x 150mm, Thermo). The trap wash solvent
was aqueous 0.05% (v:v) trifluoroacetic acid and the trapping flow rate was 15μL/min. Separa-
tion was achieved by linear multi-step gradient elution of two solvents: solvent A, aqueous 1%
(v:v) formic acid, and solvent B, aqueous 80% (v:v) acetonitrile containing 1% (v:v) formic
acid, with a capillary column flow rate of 300 nL/min and column temperature of 40˚C. The
linear multi-step gradient profile was: 3–10% B over 7 mins, 10–35% B over 30 mins, 35–99%
B over 5 mins and then proceeded to wash with 99% solvent B for 4min.
The nanoLC system was interfaced with an Orbitrap Fusion hybrid mass spectrometer
(Thermo) with an EasyNano ionisation source (Thermo). Positive ESI-MS and MS2 spectra
were acquired using Xcalibur software (version 4.0, Thermo). Instrument source settings used:
ion spray voltage, 1,900 V; sweep gas, 0 Arb; ion transfer tube temperature; 275˚C. MS1 spectra
were acquired in the Orbitrap with: 120,000 resolution, scan range:m/z 375–1,500; AGC tar-
get, 4e5; max fill time, 100 ms. Data dependant acquisition was performed in top speed mode
using a fixed 1s cycle, selecting the most intense precursors with charge states>1. Easy-IC was
used for internal calibration. Dynamic exclusion was performed for 50s post precursor selec-
tion and a minimum threshold for fragmentation was set at 5e3. MS2 spectra were acquired in
the linear ion trap with: scan rate, turbo; quadrupole isolation, 1.6m/z; activation type, HCD;
activation energy: 32%; AGC target, 5e3; first mass, 110m/z; max fill time, 100ms. Acquisitions
were arranged by Xcalibur to inject ions for all available parallelizable time.
Disulphide bonding mediates chlamydial PmpD interaction
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LC-MS/MS data analysis
Thermo .raw files were imported onto PEAKS studio 8.0 for peak picking and peptide identifi-
cation. Database searching was performed against an in-house FASTA file containing the
expected sequence of His6-tagged rPmpD, with search criteria specified as: Enzyme, none;
Variable modifications, oxidation (M), carbamidomethylation (C), beta-methylthiolation (C);
Peptide tolerance, 3ppm; MS/MS tolerance, 0.5 Da; Instrument, ESI-TRAP; Fragmentation,
HCD. PEAKS-DB results were filtered to achieve a 1% peptide false discovery rate.
Peak lists in .raw format were imported into Progenesis QI (nonlinear–Ver. 3) for relative
peak area-based quantification. LC-MS runs aligned with the reduced sample chosen as the
reference. A combined peak list was exported in .mgf format for database searching. Mascot
Daemon (version 2.5.1, Matrix Science) was used to submit the search to the Mascot program
(Matrix Science Ltd., version 2.5.1). Search criteria were identical to the PEAKS search with
the exception that an independent search was carried out for each protease specificity. Search
results were passed through Mascot Percolator to achieve a 1% peptide false discovery rate and
filtered to require a minimum expected score of 0.05 for individual matches. The Mascot .
XML result files were imported into Progenesis QI and peptide identifications associated with
precursor peak areas. MS1 peak areas were exported without normalisation for all identified
PmpD peptides. Peak areas for carbamidomethylated and methylthiolated variants of the same
peptide sequence and charge state were aligned and expressed as the relative percentage of
total peptide from intensity across the reduced and non-reduced sample.
PmpD conjugation to carboxylate-modified beads
Covalent coupling of oligomeric rPmpD or bovine serum albumin (BSA) (Sigma Aldrich) to
carboxylate-modified L4530 fluorescent beads (Sigma Aldrich) was performed by reaction
with 1mM N-Ethyl-N0-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDAC) (Sigma
Aldrich) in 50mMMES pH 6.1. 50 μg/mL, 25 μg/mL, 2.5 μg/mL and 0.25 μg/mL concentra-
tions of rPmpD (or 200 μg/mL BSA) were used for coating beads. The mixture was incubated
at 20˚C with gentle shaking for 1h and the reaction was stopped by centrifugation of the sus-
pension, discarding the supernatant, and washing the pellet twice in binding buffer (RPMI
containing 10% BSA (w/v), 10mMHEPES, pH 7.5) to remove all traces of EDAC. Coupling of
rPmpD protein to the beads was verified on SDS-PAGE by inspection of the reaction superna-
tant and boiling of coated beads at 95˚C for 5mins.
Hak cell bead adhesion and inhibition assays
Serial dilutions of beads (1:20, 1:50 and 1:100) were added to Hak cells (ATCC) in binding
buffer to determine the optimal dilution for subsequent assays. Adhesion assays with rPmpD-
coated or control (naked or BSA-coated) beads were performed on Hak cell monolayers (70–
80% confluent) in 96-well plates. For all assays, 1 mL of 1% L4530 bead suspension was used,
and beads were incubated for 1 h at 4˚C to initiate binding. Unattached beads were removed
by twice washing with PBS, and cells were fixed with methanol. Binding was quantified follow-
ing Giemsa staining, by counting the number of attached beads per 50 cells in triplicate fields
of view under phase microscopy. Filtered Giemsa stain solution consisted of 3.6 mL Sorensen
A solution (9.5g/l NaHPO4 (Sigma)), 1.4 mL Sorensen B solution (9.07g/l KH2PO4 (Sigma), 45
mL de-ionized water and 5.55 mL Giemsa stain (VWR International).
In competitive inhibition assays, Hak cell monolayers were pre-incubated with four dilu-
tions (50 μg/mL, 25 μg/mL, 2.5 μg/mL and 0.25 μg/mL) of soluble rPmpD in binding buffer in
96-well plates for 1hr at 4˚C to allow for binding. Following two washes in PBS to remove
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unbound protein, a 1:50 dilution of a 1% solution of L4530 fluorescent beads were added and
incubated for 2h at 4˚C to allow for binding.
For the serum neutralisation assays, a 1:50 dilution of a 1% solution of rPmpD-coated
L4530 fluorescent beads were separately pre-incubated with two dilutions (1:50, 1:100) of heat-
inactivated pre-immune or anti-rPmpD immune serum (obtained from immunized C57BL/6
mice) for 1h at 37˚C with gentle shaking to enable binding of antibodies to the beads. Bead-
serummixtures were then added to Hak cell monolayers (as described above), in 96-well
plates, and incubated for 2h at 4˚C to allow for binding. In both assays, unattached beads were
removed by twice washing with PBS, and cells were fixed with methanol. Enumeration of
attached beads was implemented as described above.
Mouse immunizations
All animal care and experimental procedures were performed under UK Home Office License
(Ref # PPL 70/7805) and with approval from the Animal Procedures and Ethics Committee of
the University of York. 6–8 week old female C57BL/6 mice (n = 5) were bred and maintained
in individually vented cages under specific pathogen-free conditions at the University of York,
and monitored daily for any signs of distress. Animal weight was recorded weekly to monitor
any signs of weight loss. Mice were immunized subcutaneously with three doses of monomeric
rPmpD in combination with an oil-in-water emulsion formulation of a second-generation
lipid adjuvant (SLA-SE) as previously described [8]. To obtain serum for neutralization assays,
mice were euthanized 55 days post initial immunization using a rising concentration of carbon
dioxide, and 0.5–1 mL of blood was collected via cardiac puncture using a 25G needle. Pre-
immune and anti-rPmpD serum was heat-inactivated prior to use in neutralization assays by
heating at 56˚C for 30 mins.
Results
Recombinant PmpD passenger domain purifies as a complex array of
homo-oligomers with monomeric species in low abundance
The 65 kDa PmpD fragment identified by Kiselev et al. [13] using mass spectrometry analysis
(Fig 1A) was over-expressed in E.coli strain BL21(DE3) and extracted under denaturing condi-
tions (6M GdHCl). After step-wise dialysis, refolded protein was purified with a C-terminal
His6-tag using immobilized metal affinity chromatography, followed by size exclusion chro-
matography (Fig 1B). rPmpD elutes as a complex mixture of oligomers with a broad peak (42–
65 mL) emerging shortly after the 40 mL void volume of the S200 16/60 column, with a much
smaller delineated monomeric peak between 67–75 mL. Reducing SDS-PAGE analysis of all
fractions showed exclusive representation of the rPmpD 65 kDa domain (Fig 1B, inset), and
the elution profile was consistent in multiple subsequent purifications (data not shown), indi-
cating robust methodological reproducibility. Refolding in the presence of 5mM reduced glu-
tathione and 0.5mM oxidized glutathione did not result in a change in the SEC elution profile
and a shift to monomeric protein (not shown), likely suggesting that oligomers comprise the
dominant native state of the protein in vitro. In contrast to the CtMOMP that is highly hydro-
phobic and poorly soluble in the absence of detergents and lipid bilayers [24], both monomeric
and oligomeric rPmpD were found to partition almost exclusively in to the aqueous rather
than the detergent phase during Triton X-114 phase separation of LPS (Fig 1C), showing pre-
dominantly hydrophilic properties. Interestingly, the elution profile of rPmpD closely resem-
bles that of the Pmp21 23 kDa domain previously described [18], and we next sought to
determine the biophysical characteristics of the purified Ct rPmpD 65 kDa passenger domain
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fragment, as well as delineate the biochemical mechanisms of Ct PmpD interaction and native
secondary structure.
rPmpD oligomers demonstrate polydispersity and consist primarily of ?–
sheet secondary structure
Dynamic light scattering (DLS) was carried out to assess the size distribution of species within
the two fractions. Polydispersity index (PDI) was used as a measure of sample homogeneity,
and defined as the ratio of the average molecular mass to the number average molecular mass,
with a PDI = 1.0 indicating complete monodispersity. Histograms plotting hydrodynamic
radius (nm) against particle size distribution indicate a PDI of 0.34 for the oligomeric fraction
(Fig 2A), highlighting a complex mixture of higher order rPmpD species, while monomeric
rPmpD has a PDI of 0.9, reflecting nearly complete monodispersity (Fig 2C). Regularization
histograms showing the percentage (by mass) of particles of a given hydrodynamic radius
Fig 1. Chlamydia trachomatis polymorphic membrane protein D (PmpD) schematic and elution profile. (A) Ct PmpD displays the archetypal characteristic
three-domain structure of Gram-negative bacterial type V autotransporters. Signal sequence (pink), passenger domain (blue) and Č-barrel autotransporter
(green) are depicted with the corresponding amino acid positions. The 65 kDa passenger domain fragment used in this study is depicted below, as detected by
Kiselev et al. in infected cells [13]. (B) Soluble 65 kDa rPmpD elutes as a mixture of oligomeric species (‘O’) with substantially lower concentrations of soluble
monomeric protein (‘M’). SDS-PAGE shows the chemical purity of the eluate (inset), and is representative of each collected fraction. Fractions B7-B3 (within
dashed red lines) were pooled, and comprise the ‘oligomeric’ fraction used in all downstream experiments. The flow rate used was 0.3 ml/min, and the elution
profile is representative of independent replicate purifications (n = 5). (C) rPmpD partitions exclusively in to the aqueous fraction following phase separation,
indicative of predominantly hydrophilic properties of the passenger domain.
https://doi.org/10.1371/journal.pone.0198662.g001
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within the samples are also depicted for oligomeric (Fig 2B) and monomeric (Fig 2D) rPmpD
proteoforms. Oligomeric and monomeric forms of rPmpD were further characterized by
using circular-dichroism (CD) spectroscopy. The molar ellipticity of rPmpD exhibits a shallow
minimum at 215–220 nm, typically associated with the predominance of Č-sheet structure (Fig
2E and 2F), and consistent with experimentally solved Č-helical structures of Gram-negative
T5SSs [25].
Disulphide bonding mediates oligomerization and governs native
secondary structure of rPmpD
When rPmpD was separated on reducing and non-reducing SDS gels (Fig 3A), the monomer
migrated alongside the 66 kDa molecular weight marker in both the absence and presence of
reducing agent (Lanes 3 and 6). However, oligomeric rPmpD failed to dissociate completely in
the absence of 0.5M Č–ME in the loading buffer (Lanes 1 and 2), indicative of predominantly
intermolecular disulphide bonding in the majority of species present within the mixture, with
some non-covalent interactions also present in these proteoforms that do dissociate in to con-
stitutive monomers. SDS, an anionic detergent, is sufficient to disrupt this proportion of non-
covalent interactions within the rPmpD oligomers.
Native (SDS-free) gels of monomeric and oligomeric rPmpD showed migration of mono-
meric rPmpD occurs in the absence of Č–ME (Fig 3C, Lane 8), whereas the oligomeric fraction
failed to enter and migrate in to the 5% acrylamide gel, likely due to its high molecular weight
(Fig 3B, Lane 8). The addition of reducing agents to oligomers was expected to initiate
Fig 2. rPmpDmonomeric and oligomeric forms show differing polydispersity and are comprised of Č-sheet secondary structure. rPmpD fractions were analysed
using dynamic light scattering and circular dichroism. The polydispersity index is displayed above the frequency histograms of (A) oligomeric and (C) monomeric
fractions. Regularization histograms showing %mass versus hydrodynamic radius (nm) for (B) oligomeric and (D) monomeric rPmpD fractions are also displayed,
indicating the absence of larger molecular weight proteoforms in monomeric rPmpD following size exclusion chromatography. Soluble oligomeric (E) and monomeric
(F) fractions of rPmpD were analysed using circular dichroism. Spectra for oligomeric (Peak ‘O’) and monomeric (Peak ‘M’) rPmpD fractions are indicative of
predominantly Č-sheet secondary structure interspersed with random coil elements, similar to the Pmp21 ortholog in C.pneumoniae [18].
https://doi.org/10.1371/journal.pone.0198662.g002
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dissociation in to constituent monomeric subunits, however, contrary to our expectation, the
use of three different reducing agents (Č–ME, TCEP or DTT) at a range of concentrations had
no effect on entry and migration of the oligomer in to native gels (Fig 3B, Lanes 1–6). Interest-
ingly, the migration of rPmpDmonomer was also affected by the presence of reducing agents,
increasing concentrations of which led to reduced entry and mobility of the protein (Fig 3C,
Lanes 1–6). These observations suggest that reduction of disulphide bonds in the monomer
causes the formation of higher order aggregates by disrupting native protein structure in a
concentration-dependent manner, which subsequently precludes protein entry in to the native
gel. Thus, we hypothesized that in addition to mediating intermolecular interactions, disul-
phide bonding is essential for preservation of native PmpD structure. To further address the
apparent complexity of this disulphide-bonded network, differential alkylation of monomeric
rPmpD was undertaken in an attempt to identify reduced cysteines that could potentially form
intermolecular disulphide bridges responsible for this oligomerisation.
Oligomerisation protects against digestion with trypsin
Both rPmpD monomer and oligomers were subjected to tryptic digest as described in the
Materials and Methods. Notable differences were observed between oligomeric (Fig 3D) and
monomeric rPmpD proteoforms (Fig 3E). The 65 kDa rPmpD monomer was almost
completely degraded to smaller fragments ~22 kDa and ~35 kDa after 30 minutes. In contrast,
oligomeric rPmpD showed a different proteolytic pattern, with a wider range of digest
Fig 3. Inter- and intramolecular disulphide bonding critically influence the biophysical properties of rPmpD. (A) Oligomeric (Lanes 1–3) and monomeric (Lanes
4–6) rPmpD samples were incubated with loading buffer in the absence or presence of 0.5 M Č-mercaptoethanol (Č-ME). Native gels were also run with (B) oligomeric
or (C)monomeric rPmpD samples incubated in the absence of SDS with differing concentrations of three reducing agents– 10 mM or 5 mMDTT (Lanes 1–2), 25 mM
or 2.5 mM TCEP (Lanes 3–4) and 0.5M or 50 mM Č-ME (Lanes 5–6). Non-reduced sample was run as a control (Lane 8). (D) oligomeric or (E)monomeric rPmpD
were incubated in the presence of trypsin for 30 min, 5 mins, or 2 mins (Lanes 2–4, respectively). Undigested control samples were run in Lane 1 of each gel.
https://doi.org/10.1371/journal.pone.0198662.g003
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fragments and some undigested protein still detected, indicating a resistance to tryptic proteol-
ysis. To determine the nature of biochemical interactions and address the mechanism of
assembly of oligomeric rPmpD, we employed commonly used reducing agents in native and
SDS-PAGE experiments.
All cysteine residues can form disulphide bonds in monomeric rPmpD
The aim of differential cysteine labeling was performed to identify the redox state of cysteines
in the native state of the protein. High sequence coverage was obtained for both non-reduced
(Fig 4A) and reduced (Fig 4B) rPmpD. Non-reduced monomeric rPmpD was found to con-
tain multiple instances of cysteines in both carbamidomethylated and methylthiolated forms
(Fig 4A), indicating that increased solvent-accessibility after enzymatic digestion allows for
more complete alkylation of free thiols. Cysteine residues at positions 124, 133, 143, 534 and
535 were identified exclusively post reduction (Fig 4B), suggesting these positions are fastidi-
ously disulfide bonded or remain solvent inaccessible even as post-enzymatic digested pep-
tides. The remaining 13 cysteine residues were identified in both the reduced and non-
reduced work-flows (Fig 4A and 4B). However, frequency of identification was much greater
Fig 4. Differential alkylation of rPmpD and LC-MS/MS analysis. PEAKS identified peptides for (A) non-reduced and (B) reduced rPmpD are indicated by blue lines
are mapped onto the amino acid sequence of His6-tagged rPmpD. Modified positions are annotated with coloured boxes and letters: c = carbamidomethylated cysteine
(blue); b =methylthiolated cysteine (red); o = oxidised methionine (yellow). All cysteine-containing peptides show increased sampling of methylthiolated forms
following reduction (B) suggesting that in the dominant proteoform(s) all 18 residues are likely disulfide-bonded. Methylthiolated residues at positions 124, 133, 143,
534 and 535 are identified by PEAKS exclusively post reduction (B), remaining unidentified in the non-reduced sample (A) (green boxes), suggesting that these
cysteines are fastidiously disulphide-bonded, or remain non-solvent-exposed as peptides following digestion.
https://doi.org/10.1371/journal.pone.0198662.g004
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post reduction suggesting these 13 cysteine residues are predominantly oxidized in mono-
meric rPmpD. To gain a more precise quantitative comparison the data were analysed through
Progenesis QI. Mascot derived peptide identifications were mapped onto LC-MS peak intensi-
ties and relative MS1 peak areas for carbamidomethylated and methylthiolated variants of the
same peptide compared between non-reduced and reduced monomeric rPmpD, as shown in
Table 1.
Here, the measured peak areas for methylthiolated cysteine residues in the reduced work-
flow are highly dominant. The peptide 6/<03$*'099$1&'*$,6)(*16$1)$1**$,
$$6*. containing Cys-197, is uniquely opposed to this trend, with its carbamidomethylated
form measured to be most abundant, suggesting a higher rate of non-oxidized Cys-197. How-
ever, differential labelling for Cys-197 is also quantified from three further peptide precursors
03$*'099$1&'*$,6)(*16$1)  DQG  DQG 03$*'099$1&'*$,6) 
and in these forms the post-reduction methylthiolated form accounts for over 90% of the ion
intensity–indicating that the measurement in 6/<03$*'099$1&'*$,6)(*16$1)$1*
*$,$$6*.may be a digestion artifact or a quantitative outlier. For all 18 cysteines the major-
ity of sampled forms show greater than 95% relative peak area residing in the methylthiolated
form post-reduction, suggesting that in monomeric rPmpD, all 18 cysteine residues are disu-
phide-bonded.
Monomeric and oligomeric rPmpDmediate adherence to mammalian host
cell lines
Adhesion assays incorporated 2μm diameter naked, rPmpD- or BSA-coated beads which were
incubated with mammalian epithelial-like Hak cell or murine fibroblast McCoy cell lines as
described in the Materials and Methods. Large clusters of rPmpD-coated beads can be seen
attached to the cell surface in both cell types (red arrowheads- Fig 5C and 5F), in contrast to
control beads (Fig 5A, 5B, 5D and 5E). These observations mimic the binding pattern of Chla-
mydia pneumoniae Pmp21-coated beads previously described by Molleken et al. [5], and dem-
onstrate that Ct rPmpD also possesses adhesin-like properties. No significant differences were
observed between the binding capacity of beads coated with monomeric or oligomeric rPmpD
(Fig 6A). For subsequent competitive inhibition and neutralisation assays, beads were coated
with oligomeric rPmpD. This is the dominant proteoform in vitro, and is also thought to be
the more prevalent species on the oxidized membranes of infectious EBs in vivo [12].
Beads coated with 50 μg/mL of oligomeric or monomeric rPmpD showed a significant
increase in adhesive capacity to Hak cell lines relative to naked and BSA-coated beads (Fig
6A). Titration of rPmpD bead coating concentrations from 50 μg/mL to 0.25 μg/mL was car-
ried out, and two separate dilutions (1:20 and 1:50) of a 1% solution of polystyrene beads with
Hak cells revealed a concentration-dependent reduction in bead binding (Fig 6B). A rPmpD
bead coating concentration as low as 2.5 μg/mL still effected roughly four-fold greater adhe-
sion (118±10) than beads coated with 200 μg/mL of BSA control protein (29±11), with no sig-
nificant difference from higher 50 μg/mL or 25 μg/mL coating concentrations, indicating a
saturating effect of protein concentration on the bead surface, or possible steric hindrance
caused by higher concentrations of rPmpD that may affect binding.
Next, we sought to determine whether soluble rPmpD could block rPmpD-coated bead
binding to Hak cells. Pre-incubation of Hak cells with soluble rPmpD (50 μg/mL-2.5 μg/mL)
was carried out at 4˚C, followed by washing and incubation with rPmpD-coated beads. No sig-
nificant inhibition of rPmpD-coated bead attachment is seen following pre-treatment of cells
with 10 μg/mL rPmpD. Increasing concentrations of soluble rPmpD competitor significantly
abrogate bead binding to Hak cells relative to the negative control (pre-incubation with BSA)
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Table 1. Differential cysteine labeling of monomeric rPmpD.
Peptide, Charge, Alkylation Position in Peptide Alkylation
Position in
Protein
Non-reduced—
Carbamiodomethylated
Relative Peak Area (%)
Non-reduced—
Methylthiolated
Relative Peak
Area (%)
Reduced—
Carbamiodomethylated
Relative Peak Area (%)
Reduced—
Methylthiolated
Relative Peak
Area (%)
DQVSSQGLICSFTSSNL, 2+, 10 60 0 2 0 99
DQVSSQGLICSFTSSNL, 3+, 10 60 0 1 0 99
DQVSSQGLICSFTSSNLDSPR, 2+, 10 60 0 1 0 100
DQVSSQGLICSFTSSNLDSPR, 3+, 10 60 0 0 82 0
QGVDQQDQVSSQGLICSF, 2+, 16 60 1 5 0 97
QGVDQQDQVSSQGLICSFTSSNL, 2+, 16 60 0 20 1 95
QGVDQQDQVSSQGLICSFTSSNL, 3+, 16 60 0 11 0 99
SVTNPVVFQGVDQQDQVSSQGLICSF, 2+, 24 60 0 7 0 98
SVTNPVVFQGVDQQDQVSSQGLICSF, 3+, 24 60 0 3 0 100
VEQSTLFSVTNPVVFQGVDQQDQVSSQGLICSFTSSNLDSPR, 4+, 31 60 0 2 0 98
ASCSSLEQGGACAAQSIL, 2+, 3, 12 133 0 0 0 100
DCQGLQVKHCTTAVNAEGSSAN, 2+, 2, 10 151 0 0 0 99
DCQGLQVKHCTTAVNAEGSSAN, 3+, 2, 10 151 0 1 0 99
HCTTAVNAEGSSANDHLGFGGGAFFVTGSLSGEK, 4+, 2 151 0 1 10 77
MPAGDMVVANCDGAISF, 2+, 11 197 0 3 0 98
MPAGDMVVANCDGAISFEGNSANF, 2+, 11 197 0 6 0 98
MPAGDMVVANCDGAISFEGNSANF, 3+, 11 197 0 4 0 96
SLYMPAGDMVVANCDGAISFEGNSANFANGGAIAASGK, 3+, 14 197 18 0 0 98
ALSGGAIAASSDIAFQNCAELVFK, 2+, 18 255 0 3 0 98
ALSGGAIAASSDIAFQNCAELVFK, 3+, 18 255 1 3 0 87
DIAFQNCAELVFKGNCAIGTE, 2+, 7, 16 255 0 1 0 100
DIAFQNCAELVFKGNCAIGTE, 3+, 7, 16 255 0 1 0 98
SGGAIAASSDIAFQNCAEL, 2+, 16 255 0 4 0 96
SGGAIAASSDIAFQNCAELVF, 2+, 16 255 0 3 0 97
KGNCAIGTEDKGSLGGGAISSL, 3+, 4 264 0 1 0 99
KGNCAIGTEDKGSLGGGAISSLGTVL, 3+, 4 264 0 2 0 98
DKGSLGGGAISSLGTVLLQGNHGITC, 2+, 26 295 0 1 0 99
DKGSLGGGAISSLGTVLLQGNHGITC, 3+, 26 295 0 2 0 98
GSLGGGAISSLGTVLLQGNHGITCDK, 2+, 24 295 0 1 0 99
GSLGGGAISSLGTVLLQGNHGITCDK, 3+, 24 295 0 2 0 98
GSLGGGAISSLGTVLLQGNHGITCDKNESASQGGAIFGK, 3+, 24 295 0 2 0 98
GSLGGGAISSLGTVLLQGNHGITCDKNESASQGGAIFGK, 4+, 24 295 0 2 0 98
GTVLLQGNHGITCDKNESASQGGAIF, 2+, 13 295 0 0 0 100
GTVLLQGNHGITCDKNESASQGGAIF, 3+, 13 295 0 2 0 98
LQGNHGITCDKNESASQGGAIF, 2+, 9 295 0 1 0 99
LQGNHGITCDKNESASQGGAIF, 3+, 9 295 0 3 0 96
DKNESASQGGAIFGKNCQIS, 2+, 17 312 0 0 0 100
DKNESASQGGAIFGKNCQIS, 3+, 17 312 0 1 0 99
(Continued)
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Table 1. (Continued)
Peptide, Charge, Alkylation Position in Peptide Alkylation
Position in
Protein
Non-reduced—
Carbamiodomethylated
Relative Peak Area (%)
Non-reduced—
Methylthiolated
Relative Peak
Area (%)
Reduced—
Carbamiodomethylated
Relative Peak Area (%)
Reduced—
Methylthiolated
Relative Peak
Area (%)
DKNESASQGGAIFGKNCQISDNEGPVVFR, 3+, 17 312 0 0 0 100
DKNESASQGGAIFGKNCQISDNEGPVVFR, 4+, 17 312 0 1 0 99
GKNCQISDNEGPVVF, 2+, 4 312 0 1 0 99
NCQISDNEGPVVFR, 2+, 2 312 0 1 0 99
DSTACLGGGAIAAQEIVSIQNNQAGISFEGGK, 3+, 5 329 12 1 10 77
RDSTACLGGGAIAAQEIVSIQNNQAGISFEGGKASF, 3+, 6 329 0 2 0 98
RDSTACLGGGAIAAQEIVSIQNNQAGISFEGGKASF, 4+, 6 329 0 3 0 97
DISKNLGAISFSRTLCTTS, 2+, 16 396 0 0 0 100
DISKNLGAISFSRTLCTTS, 3+, 16 396 0 0 0 100
SRTLCTTSDLGQMEY, 2+, 5 396 0 1 0 98
EQNRLQCSEEEATL, 2+, 7 524 0 4 0 96
EQNRLQCSEEEATLL, 2+, 7 524 0 2 0 97
DFSRNIASLGGGALQASEGNCELV, 2+, 21 605 0 2 0 98
DFSRNIASLGGGALQASEGNCELV, 3+, 21 605 0 1 0 99
GGGALQASEGNCELVDNGY, 2+, 12 605 0 2 0 98
NIASLGGGALQASEGNCELVDNGYVLFR, 2+, 17 605 0 2 0 98
NIASLGGGALQASEGNCELVDNGYVLFR, 3+, 17 605 0 2 0 98
NIASLGGGALQASEGNCELVDNGYVLFRDNR, 3+, 17 605 0 2 0 98
GRVYGGAISCLR, 3+, 10 629 0 13 0 87
VYGGAISCLR, 1+, 8 629 0 0 0 100
VYGGAISCLR, 2+, 8 629 0 1 0 99
GGLEFASCSSLEQGGACAAQSILIHDCQGLQVK, 3+, 8, 17, 27 124, 133,
143
0 0 0 100
GGLEFASCSSLEQGGACAAQSILIHDCQGLQVK, 4+, 8, 17, 27 124, 133,
143
0 0 0 100
DLIFEKIKGGLEFASCSSLEQGGACAAQSILIH, 3+, 16, 25 124, 133 0 18 0 99
DLIFEKIKGGLEFASCSSLEQGGACAAQSILIH, 4+, 16, 25 124, 133 0 1 0 96
IHDCQGLQVKHCTTAVNAEGSSANDHLGF, 3+, 4, 12 143, 151 0 0 0 100
IHDCQGLQVKHCTTAVNAEGSSANDHLGF, 4+, 4, 12 143, 151 0 2 0 98
IHDCQGLQVKHCTTAVNAEGSSANDHLGF, 5+, 4, 12 143, 151 0 0 0 100
GNCAIGTEDKGSLGGGAISSLGTVLLQGNHGITCDK, 4+, 3, 34 264, 295 0 0 0 100
GNCAIGTEDKGSLGGGAISSLGTVLLQGNHGITCDKNESASQGGAIFGK, 4+, 3, 34 264, 295 0 2 0 98
GNCAIGTEDKGSLGGGAISSLGTVLLQGNHGITCDKNESASQGGAIFGK, 5+, 3, 34 264, 295 0 1 0 99
DKGSLGGGAISSLGTVLLQGNHGITCDKNESASQGGAIFGKNCQISDNEGPVVFR,
5+, 26, 43
295, 312 0 3 0 97
LQGNHGITCDKNESASQGGAIFGKNCQISDNEGPVVF, 3+, 9, 26 295, 312 0 0 0 100
LQGNHGITCDKNESASQGGAIFGKNCQISDNEGPVVF, 4+, 9, 26 295, 312 0 1 0 99
GKNCQISDNEGPVVFRDSTACL, 3+, 4, 12 312, 329 0 0 0 100
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Table 1. (Continued)
Peptide, Charge, Alkylation Position in Peptide Alkylation
Position in
Protein
Non-reduced—
Carbamiodomethylated
Relative Peak Area (%)
Non-reduced—
Methylthiolated
Relative Peak
Area (%)
Reduced—
Carbamiodomethylated
Relative Peak Area (%)
Reduced—
Methylthiolated
Relative Peak
Area (%)
LQCSEEEATLLGCCGGGAVHGMDSTSIVGNSSVR, 3+, 3, 12, 14 524, 534,
535
0 0 0 100
GCCGGGAVHGMDSTSIVGNSSVRFGNNY, 3+, 2, 3 533, 534 0 0 0 100
GCCGGGAVHGMDSTSIVGNSSVRF, 3+, 2, 3 534, 535 0 0 0 100
Relative peak areas of carbamidomethylated and methylthiolated peptide forms pre- and post-reduction as extracted from Progenesis QI
https://doi.org/10.1371/journal.pone.0198662.t001
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(Fig 6C). A 50 μg/mL rPmpD competitor concentration elicits ~55–60% reduction in bead
adhesion.
Finally, to further investigate whether rPmpD was essential for adhesion, heat-inactivated
pre-immune or anti-rPmpD serum from immunized C57BL/6 mice was pre-incubated with
rPmpD-coated beads. We previously showed that this anti-rPmpD serum recognizes both
rPmpD and UV-inactivated Ct EBs in ELISA assays, indicating recognition of native PmpD
protein on chlamydial bacteria [8]. Two dilutions of immune serum (1:100 and 1:50) were
incubated with rPmpD-coated beads (Fig 6D). Following addition of the serum-bead mixture
to Hak cell monolayers, ~80% reduction in adhesion was observed with a 1:50 dilution of
immune serum relative to the negative control (pre-immune serum).
Discussion
Ct PmpD is a highly immunogenic chlamydial antigen following natural infection in humans
with a range of serovars [26, 27]. In line with the degree and frequency of immunogenicity
observed during the course of natural infections, we have recently shown that immunization
with rPmpD elicits robust humoral and cell-mediated immunity that confer protection in a
mouse model of genital Ct infection, and further confirmed the presence of ocular anti-
rPmpD antibodies elicited following intramuscular immunization [8, 17]. Furthermore, other
bacterial T5SSs have been included in licensed prophylactic acellular vaccines that include the
Bordetella pertussis pertactin type Va autotransporter [28], and the more recently developed
Fig 5. rPmpD-coated beads form adhesion clusters on the surface of mammalian cell lines. Syrian hamster kidney (Hak) cell lines (PanelsA-C) or murine fibroblast
(McCoy) cell lines (PanelsD-F) were incubated with naked (A,D), BSA-coated (B,E) or rPmpD-coated (C,F) beads. Large clusters of rPmpD-coated beads are observed
on the surfaces of both Hak andMcCoy cell lines (red arrows). BSA-coated and naked beads do not demonstrate this aggregative property on the cell surface. Images
were acquired at 10x magnification (Scale bar = 20 μm).
https://doi.org/10.1371/journal.pone.0198662.g005
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quadravalent 4CMenB vaccine (Bexsero), which contains the Neisseria meningitidis adhesin A
(NadA) protein, a type Vc autotransporter [29]. In our study, we have utilized both biochemi-
cal and biophysical analytical techniques to further characterize rPmpD, a highly promising
chlamydial vaccine antigen, importantly elucidating a previously undescribed mechanism of
bacterial T5SS assembly involving an extensively disulphide-linked network of cysteine
residues.
Early studies on the COMC showed that Ct EBs and RBs from both Chlamydia psittaci and
Ct species were not solubilised by the anionic detergent SDS, unless reducing agents were pres-
ent [21]. In addition, most of the chlamydial MOMP, that comprises roughly 65% of the
COMC, was shown to exist in monomeric form within RBs, with membranes more readily dis-
sociable using anionic detergents, while EBs possess a large proportion of disulphide-linked
Fig 6. Adhesion of rPmpD-coated beads to Hak cells is inhibited by soluble rPmpD and anti-rPmpD serum. (A) Carboxylate-modified beads were coated with
oligomeric or monomeric rPmpD (50 μg/ml) and compared to control (naked or 200 μg/ml BSA-coated beads) at two different bead dilutions. The number of rPmpD-
coated beads adhered to 50 cells within triplicate fields of view was counted. Significantly enhanced adhesive capacity compared to naked or BSA-coated beads was
observed, although no significant difference in adhesion was observed between beads coated with oligomeric and monomeric rPmpD proteoforms (B) Titration of
oligomeric rPmpD (50 μg/ml-0.25 μg/ml) prior to bead coating shows a pronounced concentration-dependent reduction in adhesion. Significance values are reported
relative to BSA-coated beads. (C) Soluble rPmpD competitor protein significantly reduces adhesion of rPmpD-coated beads in a dose-dependent manner, likely
indicating competitive binding of putative host cell receptor(s). Significance is measured relative to pre-incubation with BSA only. (D)Heat-inactivated anti-rPmpD
serum obtained from rPmpD-immunized mice abrogates adhesion of rPmpD-coated beads. Bead coating concentration of rPmpD varied from 50 μg/ml-2.5 μg/ml.
Significance is measured relative to a 1:50 dilution of heat-inactivated pre-immune serum. All data are representative of 3 separate experiments, and presented as
mean ± standard deviation. For all experiments, statistical significance was determined using a two-tailed t-test with GraphPad Prism 6.  = p0.05,  p0.01,
p0.001.
https://doi.org/10.1371/journal.pone.0198662.g006
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trimeric MOMP [24]. These findings were supported by our observations for rPmpD under
non-reducing and reducing SDS PAGE, which indicate that even more extensive covalent dis-
ulphide bonding leads to formation of oligomeric complexes. Our data expand upon recent
findings involving the 23 kDa Chlamydia pneumoniae Pmp21 passenger domain fragment,
where a different mechanism of oligomeric interaction involving FxxN repeat motifs was pro-
posed [18]. Indeed, we have observed that non-covalent interactions may also contribute to
assembly of of rPmpD oligomers, evidenced by the dissociation of some monomeric protein in
non-reducing SDS PAGE, although it is apparent that disulphide bonding is yet another
important mechanism by which these cysteine-rich T5SS proteins interact, and it is likely that
both types of interaction may occur in multiple chlamydial species.
The functional role for this extensively disulphide-bonded network is not well-character-
ised due to challenging experimental ramifications of the use of reducing and alkylating agents
in vivo. However, it has previously been shown that the 67 kDa MOMP trimer was completely
recalcitrant to digestion by trypsin even when incubated at 37˚C for 20h, whereas monomeric
MOMP was susceptible to cleavage by the enzyme [24]. Disulphide bonds were present
between monomers in trimers and indeed, between trimers themselves, thus indicating that
intermolecular disulphide interactions may be responsible for proteolytic recalcitrance. Pro-
teolytic digests on monomeric and oligomeric rPmpD in our investigations show similar par-
allels to the respective MOMP proteoforms. Indeed, the array of polarized flower-like
structures observed in the first electron micrograph images of PmpD on chlamydial EBs are
consistent with the formation of oligomeric outer membrane structures [12].
LC-MS/MS analysis spans near complete sequence coverage of monomeric rPmpD, and,
crucially, covers all cysteine residues. The presence of disulfide bonds was assessed by compar-
ing the relative abundance of methylthiolated cysteine-containing peptides (pre- and post-
reduction). Surprisingly, we found that widespread intramolecular cysteine-cysteine interac-
tions contribute to the preservation of monomeric rPmpD secondary structure in vitro, though
it is unclear in which form the protein predominantly exists in vivo, and whether this pattern
of assembly remains, or is altered during each stage of biphasic development or secretion
through the T5SS apparatus. All cysteine-containing peptides show increased sampling and
intensity of methylthiolated forms post reduction suggesting that in monomeric rPmpD, all 18
residues exist in disulfide pairs. The LC-MS/MS data also suggest that there is a population of
much lower abundance proteoforms in which a number of cysteines are present in the reduced
form prior to chemical reduction. However, resolving these low abundance proteoforms is not
possible from these data. For instance, there may be one proteoform where all cysteines are
reduced or several forms in which two different cysteines are not cross-linked. This may sug-
gest pleomorphic or misfolded conformational states of monomeric rPmpD subunits, which
cannot be excluded due to the formidably extensive network of cysteine residues in the passen-
ger domain.
Considering that rPmpD is likely comprised of variable homo-oligomeric species in vitro,
and given the large numbers of cysteines dispersed throughout the protein, some residues may
not have to be involved in the formation of higher-order oligomeric forms, forming intramo-
lecular disulphide bonds, or existing as non-solvent-accessible free thiols. From the data pre-
sented here, these potentially include methylthiolated cysteines 124, 133, 143, 534 and 535
identified exclusively post-reduction by Peaks. Intramolecular disulphide bonds have also
been shown to be important in the most well-characterized T5SS, the invasin protein from
Yersinia sp., where the formation of the disulphide bond between Cys906 and Cys982 is critical
for integrin binding [30]. Thus, cysteine interactions in T5SSs may fastidiously contribute to
the preservation of optimal conformational structures, playing important roles in modulating
the functionality of these proteins.
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Here, we show that rPmpDmonomers and oligomers play a role in mediating host cell
adhesion, and in competitive inhibition assays, it is likely that binding of soluble rPmpD to a
putative cellular receptor or extracellular matrix component in Hak cells competes for binding
sites available to rPmpD-coated beads on the cell surface. In addition, anti-rPmpD serum
abrogates bead binding to the cell surface in a dose-dependent manner. Hence, our data are
consistent with previous findings in the field regarding the perceived function of Pmps as
adhesins in other chlamydial species [5, 6, 18, 19]. It has been proposed that oligomerisation of
bacterial cell surface proteins may be a means of enhancing adhesion through the incorpo-
ration of a greater concentration of binding sites [31]. Indeed, it has been shown for a trun-
cated C-terminal 23 kDa passenger domain fragment of Pmp21, that oligomers mediate
significantly greater adhesion to host cells than monomers [18]. However, in contrast, our data
suggest no significant differences in adhesion between monomeric and oligomeric rPmpD
proteoforms. This may be due to stark differences in the size of recombinant fragments used
in the two studies. Luczak et al. utilise a 23 kDa C.pneumoniae Pmp21 domain, which contains
only 2 FxxN repeat motifs [18]. In our study, we express the 65 kDa PmpD passenger domain
fragment which is roughly three times the size, and a more likely physiological representation
of an in vivo scenario, as it has previously been identified by mass spectrometry from infected
cell lysates [13]. This rPmpD fragment contains 13 FxxN and 12 GGA(I,L,V) repeat motifs
that are hypothesized to mediate adhesion in C.pneumoniae [19]. Hence, monomeric rPmpD
may be sufficient to mediate adhesion as well as oligomeric proteoforms.
Certainly, the predominance of rPmpD in several full-length and processed forms on ele-
mentary and reticulate bodies (shown in electron micrographs), does suggest that the protein
may exist in a variety of conformations on the chlamydial membrane in vivo, the functional
relevance of which is not yet known [12]. Moreover, in addition to intermolecular interactions
within the bacterial outer membrane itself, modification of thiol residues in cysteine-rich
Pmps may initiate interaction with host cell components, facilitating internalization. Direct
modification of thiols at the host cell interface by host-derived protein disulphide isomerase
has been implicated in mediating chlamydial adhesion and invasion, as well as the internaliza-
tion of important viral pathogens such as the human immunodeficiency virus and Newcastle
disease virus, as well as cleavage of diphtheria toxin. Cysteine-rich Pmp adhesins could play
roles in initiating invasion through similar mechanisms [32–35].
Conclusion
In summary, the data gathered in this study provide advancement in our understanding of
chlamydial polymorphic membrane protein secondary structure and intermolecular assembly
in vitro. We have shown that in addition to non-covalent interactions, extensive disulphide-
mediated covalent interactions play a role in formation of higher-order structures, which rep-
resent a previously undescribed mechanism of T5SS self-association that differs markedly
from other bacterial species and may be unique to the Chlamydiaceae. Subsequent work aims
to assess whether modification of these disulphide interactions influences protein function in
vitro and in vivo, in order to gain a more comprehensive molecular understanding of chlamyd-
ial membrane protein assembly. PmpD also displays an adhesin-like function in vitro, and
future studies will aim to identify putative host cell ligands, as knowledge of Ct binding to
human epithelial cells still remains rudimentary.
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